PAK2 and prostate carcinoma: SKP2 has been shown to also affect AR ubiquitination [139], but additionally its targets in prostate cancer include EZH2, p27, JARID1B, DAB2IP, AKT, BRCA2, ATF4, p27, p21, and Twist to regulate various cellular processes (Table 3).